case_images: PMC10879427_01
case_images: Bone marrow (BM) cells of the patient at the time of diagnosis. (A) Myeloblasts and promyelocytes in BM cell morphology. May-Gruenwald Giemsa stain, 100x. (B) Acquired Pelger-Huet anomaly and granulocytic dysplasia in BM cell morphology. May-Gruenwald Giemsa stain, 100x. (C) Hypercellular with granulocytic hyperplasia in BM cell morphology. May-Gruenwald Giemsa stain, 10x. (D) Hypercellular with granulocytic hyperplasia in BM biopsy. Hematoxylin-eosin stain. 40x.
case_images: fonc-14-1353818-g001.jpg
case_images: PMC10879427_01_fonc-14-1353818-g001.jpg
case_images: f1
case_images: Granulocyte hyperplasia was extremely active, and obvious morphological abnormalities were observed ( Figure 1 ).
case_images: Clinical course after starting hydroxyurea (HU) and decitabine. WBC, white blood cell; Hb, hemoglobin; PLT, platelet; LMC, left midcostochondral line; AZA, azacitidine.
case_images: fonc-14-1353818-g002.jpg
case_images: PMC10879427_01_fonc-14-1353818-g002.jpg
case_images: f2
case_images: Blood tests revealed a WBC count of 20.77 x 109/L, a hemoglobin concentration of 99 g/L, and a PLT count of 35 x 109/L ( Figure 2 ).